Heartland - AACE 8th Annual Meeting

Kansas City, MO US
August 18, 2017 to August 20, 2017

Target Audience

Endocrinologists, MDs & DOs, advanced practice clinicians and other healthcare professionals interested in the treatment of endocrine disease living or working in Arkansas, Kansas, Missouri, Nebraska and Oklahoma.

Learning Objectives

  1. Understand the relationship between glucose control and cardiovascular outcomes in patients with Type 2 Diabetes
  2. Describe the results of recent CV outcomes trials of glucose lowering agents in patients with Type 2 Diabetes
  3. Understand the results of CVD-REAL study and its potential implications in clinical practice
  4. Identify appropriate candidates for testosterone replacement therapy
  5. Monitor testosterone replacement therapy
  6. Acknowledge side-effects of testosterone therapy
  7. Recognize type 2 diabetes as primarily a lifestyle related disease
  8. Define a whole-food plant-based diet
  9. Summarize the use of a whole-food-plant-based in the prevention and treatment of type 2 diabetes
  10. Better understanding of the multisystem nature of the renal stones
  11. Better understanding of the pathophysiology of renal stones
  12. Better understanding of the role of diet and medical management of renal stones
  13. Describe infrastructure required and interpretation strategies for downloading meter/pumps/sensors
  14. Review use of new sensor and sensor pump technologies for the endocrinologist in 2017
  15. Review future technologies for diabetes management
  16. Review the data supporting the wide range of glucose values for any given HbA1C
  17. Review the various common and uncommon reasons for glycation gaps
  18. Review when alternative biomarkers will be effective and when they won't be
  19. An overview of emerging techniques for tumor resection
  20. Craniopharyngiomas: Special considerations
  21. Centers of excellence for pituitary tumors
  22. Recognize multidisciplinary needs of girls with Turner Syndrome
  23. Know recent changes in the recommendations for care in Turner Syndrome
  24. Identify areas where further research is needed in the care of Turner Syndrome
  25. Identify patients with fatty liver at risk for development of progressive liver disease
  26. Recognize NAFLD/NASH as an important cause or morbidity and mortality in patients wiht metabolic syndrome
  27. Optimize diagnostic and treatment strategies in patients with NASH in order to improve outcomes
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 10.00 AMA
  • 10.00 Attendance
Course opens: 
08/18/2017
Course expires: 
08/20/2018
Event starts: 
08/18/2017 - 7:00pm
Event ends: 
08/20/2017 - 10:30am
Cost:
$0.00

Friday, August 18, 2017

7:00 - 8:30 PM

Social / Dinner Program – Brio Tuscan Grill
Country Club Plaza, 502 Nichols Rd, Kansas City, MO 64112

7:30 - 8:30 PM

The Coming Paradigm Shift in the Management of Type 2 Diabetes 
Mikhail Kosiborod, MD, FACC, FAHA
 

Saturday, August 19, 2017

7:00 - 8:00 AM

Registration / Continental Breakfast 

8:00 - 8:15 AM

Welcome / Pre-Program Assessment 

8:15 - 9:15 AM

Testosterone Replacement Therapy in Men: An update 
Sandeep Dhindsa, MD

9:15 - 10:15 AM

Food as Medicine: The role of a whole-food plant-based diet in the prevention and treatment of type 2 diabetes 
James Loomis, MD, MBA

10:15 - 10:45 AM

Break 

10:45 - 11:45 AM

Evaluation and Management of Renal Stone 
Bahar Bastani, MD

11:45 - 12:45 PM

Diabetes Technologies for the Endocrinologist in 2017 
Irl B. Hirsch, MD

12:45 - 1:45 PM

Lunch

1:45 - 2:45 PM

New Thinking About an Old Test: HbA1c 
Irl B. Hirsch, MD

2:45 - 3:45 PM

Advances in Pituitary Tumor Surgery 
Saleem I. Abdulrauf, MD, FACS

3:45 - 4:00 PM

Post-Program Assessment

Sunday, August 20, 2017

7:45 - 8:00 AM

Coffee Break

8:00 - 8:15 AM

Pre-Program Assessment

8:15 - 9:15 AM

Update on Care of Turner Syndrome 
Joseph Cernich, MD, FAAP

9:15 - 10:15 AM

NAFLD: An overview and emergent trends 
Laura M. Alba, MD 

10:15 - 10:30 AM

Post-Program Assessment

10:30 AM

Family Brunch

Intercontinental on the Plaza
401 Ward Parkway
Kansas City, MO 64112
United States

Saleem I. Abdulrauf, MD, FACS

Professor and Chairman

Department of Neurosurgery

Saint Louis University

School of Medicine

St. Louis, MO USA

Laura M. Alba, MD

Saint Luke's Transplant Specialists

Assistant Professor of Medicine

UMKC School of Medicine

Kansas City, MO

Bahar Bastani, MD

Professor of Medicine – Nephrology

Saint Louis University

St Louis, MO

Joseph Cernich, MD

Pediatric Endocrinology

Children’s Mercy Kansas City

Associate Professor, Dept. of Pediatrics

UMKC School of Medicine

Kansas City, MO

Sandeep Dhindsa, MD, FACE

Associate Professor of Medicine

Director, Division of Endocrinology and Metabolism

Saint Louis University

St. Louis, MO

Irl B. Hirsch, MD

Professor of Medicine

University of Washington School of Medicine

Seattle, WA

Mikhail Kosiborod, MD, FACC, FAHA

Professor of Medicine

University of Missouri Kansas City School of Medicine

Saint Lukes Mid America Heart Institute

Kansas City, MO

James F. Loomis, MD, MBA

Medical Director

Barnard Medical Center 

Washington,  DC

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.00 AMA
  • 10.00 Attendance

Accreditation Period

Course opens: 
08/18/2017
Course expires: 
08/20/2018

Price

Cost:
$0.00
Please login or register to take this course.